SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.68-2.4%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robohogs who wrote (28130)7/28/2009 5:30:53 PM
From: tuck1 Recommendation  Read Replies (4) of 52153
 
OT: chasing yield for IRA: Jon, IJ, and whoever dabbles in the credit services companies . . . there has been a tremendous run in the CS companies of late. After collecting several pretty nice dividends and some capital gains on BKCC, I pitched it out of my IRA today. I'm with Peter, I think the market is getting ahead of itself here, though earnings have been better than expected. I don't think that latter trend is going to last. In light of richer valuations of these companies, I was wondering if you had any ideas in this space. I'm looking at MFA, which is similar to NLY but more cheaply valued and with similar yield. They just announced a stock offering, which is hurting it a few per cent after hours. Akin to HGSI's raise, this is probably a good time to do it. I'm tempted to start a position, and add more aggressively as the market pulls back. If the market doesn't pull back, I can only hope it takes my chief biotech holding, MNTA, with it.

MFA is paying out its dividend in a couple of days, so I've got some time to become a shareholder and still collect the next one.

Also checking out NLY, TCAP.

Thoughts?

TIA & Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext